Piedmont Healthcare Report issue

Academic/Hospital Phase 1 Phase 3

Organization Overview

First Clinical Trial
2009
NCT01030328
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Piedmont Atlanta Hospital | Piedmont Atlanta Hospital, Atlanta, GA | Piedmont Healthcare

Active Ingredients

Drugs in Phase 3 Trials (1)

fenofibrate (fenoglide) (1 trial)

Drugs in Phase 1 Trials (1)

spironolactone (aldactone) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atherosclerosis (Phase 3)

Atrial Fibrillation (Phase 1)

Coronary Artery Disease (Phase 3)

Myocardial Ischemia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2